Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16168 | 28526997 | Adv Ther | NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. | 2017 | Details |
| A16175 | 28521870 | Metabolism | The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. | 2017 | Details |
| A16192 | 28511152 | Wiad Lek | [Pathogenetic substantiation of complex treatment of nonalcoholic steatohepatitis and steatosis in patients with pre-diabetes and type 2 diabetes]. | 2017 | Details |
| A16197 | 28508477 | Hepatology | The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. | 2017 | Details |
| A16198 | 28508194 | Endocrine | Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. | 2017 | Details |
| A16200 | 28507930 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease in South Asians: A Review of the Literature. | 2017 | Details |
| A16202 | 28507837 | Cureus | Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias. | 2017 | Details |
| A16204 | 28507343 | Sci Rep | Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. | 2017 | Details |
| A16211 | 31646122 | Cardiovasc Endocrinol | Nonalcoholic fatty liver disease: implications for cardiovascular risk. | 2017 | Details |
| A16212 | 28505074 | Nutrients | NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet. | 2017 | Details |
| A16221 | 28502513 | J Clin Lipidol | Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia. | 2017 | Details |
| A16222 | 28502444 | Pediatr Clin North Am | Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications. | 2017 | Details |
| A16234 | 28494529 | Clin Mol Hepatol | NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs. | 2017 | Details |
| A16235 | 28493399 | Echocardiography | Diagnosis of fatty liver by computed tomography coronary artery calcium score. | 2017 | Details |
| A16246 | 28484681 | Cureus | Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis. | 2017 | Details |
| A16255 | 28483030 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | Value and Progress of Ultrasound in Diagnosis and Treatment of Hyperuricemia. | 2017 | Details |
| A16279 | 28471965 | Medicine (Baltimore) | Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study. | 2017 | Details |
| A16280 | 28471945 | AIDS | Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver. | 2017 | Details |
| A16312 | 28464369 | Aliment Pharmacol Ther | Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. | 2017 | Details |
| A16316 | 28462811 | Trends Endocrinol Metab | Sphingolipids and Lipoproteins in Health and Metabolic Disorders. | 2017 | Details |
| A16321 | 28460349 | Cancer Epidemiol | Nonalcoholic fatty liver disease and mortality among cancer survivors. | 2017 | Details |
| A16345 | 28445310 | Medicine (Baltimore) | Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy. | 2017 | Details |
| A16348 | 28443804 | J Am Coll Nutr | 25(OH)D Levels in Relation to Gender, Overweight, Insulin Resistance, and Inflammation in a Cross-Sectional Cohort of Northern Italian Workers: Evidence in Support of Preventive Health Care Programs. | 2017 | Details |
| A16355 | 28441694 | J Hypertens | Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease. | 2017 | Details |
| A16357 | 28441156 | Curr Opin Lipidol | Interpreting lipoproteins in nonalcoholic fatty liver disease. | 2017 | Details |
| A16383 | 28426815 | PLoS One | Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study. | 2017 | Details |
| A16428 | 28395890 | Am J Cardiol | Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans. | 2017 | Details |
| A16435 | 28391883 | J Clin Lipidol | Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases. | 2016 | Details |
| A16436 | 28389566 | J Biol Chem | Microbial metabolites in health and disease: Navigating the unknown in search of function. | 2017 | Details |
| A16460 | 28375109 | Pak J Pharm Sci | Anti hyperlipidemic and hepatoprotective effects of native date fruit variety "Aseel" (Phoenix dactylifera). | 2016 | Details |
| A16466 | 28371239 | Liver Int | The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. | 2017 | Details |
| A16483 | 28361809 | Ann Ist Super Sanita | Association of non-alcoholic fatty liver disease and cardiometabolic risk factors with early atherosclerosis in an adult population in Southern Italy. | 2018 | Details |
| A16486 | 28359183 | Expert Opin Drug Metab Toxicol | Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease. | 2017 | Details |
| A16511 | 28346857 | Metab Syndr Relat Disord | The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome. | 2017 | Details |
| A16512 | 28346567 | J Nutr Health Aging | Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial. | 2017 | Details |
| A16552 | 28319895 | Redox Biol | Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review. | 2017 | Details |
| A16563 | 28314735 | Gut | Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. | 2017 | Details |
| A16586 | 28297791 | Zhonghua Gan Zang Bing Za Zhi | [Research on the natural history of non-alcoholic fatty liver disease should be taken seriously]. | 2017 | Details |
| A16589 | 28296807 | Transplantation | Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis. | 2017 | Details |
| A16591 | 28294699 | J Med Food | Chia Oil-Enriched Restructured Pork Effects on Oxidative and Inflammatory Status of Aged Rats Fed High Cholesterol/High Fat Diets. | 2017 | Details |
| A16593 | 28294174 | Eur J Clin Nutr | Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study. | 2017 | Details |
| A16596 | 28293093 | World J Gastroenterol | Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. | 2017 | Details |
| A16647 | 28266792 | J Clin Hypertens (Greenwich) | The science of salt: A regularly updated systematic review of salt and health outcomes (December 2015-March 2016). | 2017 | Details |
| A16666 | 28256088 | Diabetes Obes Metab | Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database. | 2017 | Details |
| A16700 | 28235613 | J Hepatol | Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD. | 2017 | Details |
| A16726 | 28220621 | J Diabetes | Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease. | 2017 | Details |
| A16733 | 28218263 | Nat Rev Nephrol | Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. | 2017 | Details |
| A16738 | 28215516 | Dig Liver Dis | AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. | 2017 | Details |
| A16744 | 28212710 | Adv Clin Chem | CTRP1 in Liver Disease. | 2016 | Details |
| A16751 | 28210913 | Int Urol Nephrol | Dietary and commercialized fructose: Sweet or sour? | 2017 | Details |
| A16775 | 28185191 | Methods Mol Biol | A Coupled Approach Utilizing Immunohistochemistry and Immunocytochemistry to Visualize Cellular Lipophagy. | 2017 | Details |
| A16784 | 28178565 | Cell Metab | Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. | 2017 | Details |
| A16785 | 28178440 | Rambam Maimonides Med J | Comorbidities in Patients with Psoriatic Arthritis. | 2017 | Details |
| A16794 | 28169509 | Obesity (Silver Spring) | Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: The CARDIA study. | 2017 | Details |
| A16796 | 28167864 | J Inflamm (Lond) | Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs. | 2017 | Details |
| A16816 | 28155627 | Curr Vasc Pharmacol | Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity. | 2017 | Details |
| A16821 | 28152105 | PLoS One | Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. | 2017 | Details |
| A16822 | 28149843 | Ann Transl Med | Gamma-glutamyl transferase and cardiovascular disease. | 2016 | Details |
| A16828 | 28144387 | World J Hepatol | From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease. | 2017 | Details |
| A16831 | 28142119 | Biomed Pharmacother | Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice. | 2017 | Details |
| A16833 | 28139281 | Clin Nutr | Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. | 2017 | Details |
| A16852 | 28126503 | Presse Med | [Pathophysiology of obstructive sleep apnea syndrome and its cardiometabolic consequences]. | 2017 | Details |
| A16874 | 28115925 | PPAR Res | PPARs and Mitochondrial Metabolism: From NAFLD to HCC. | 2016 | Details |
| A16882 | 28112071 | J Dev Orig Health Dis | Early life programming and the risk of non-alcoholic fatty liver disease. | 2017 | Details |
| A16884 | 28111263 | Pharmacol Res | An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations. | 2017 | Details |
| A16907 | 28100008 | Hepatology | Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. | 2017 | Details |
| A16908 | 28099601 | An Bras Dermatol | Psoriasis comorbidities: complications and benefits of immunobiological treatment. | 2017 | Details |
| A16941 | 28082024 | Clin Chim Acta | Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: Interrelationship with age. | 2017 | Details |
| A16942 | 28081780 | Metabolism | Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by 18F-fluorodeoxyglucose positron emission tomography. | 2016 | Details |
| A16943 | 28081779 | Metabolism | Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. | 2016 | Details |
| A16947 | 28078997 | Curr Med Chem | Lipoprotein (a) and Cardiovascular Risk: The Show Must go on. | 2017 | Details |
| A16948 | 28077863 | Int J Obes (Lond) | What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? | 2017 | Details |
| A16971 | 28069746 | Postgrad Med J | Non-alcoholic fatty pancreas disease. | 2017 | Details |
| A16996 | 28053786 | Int J Hepatol | Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17001 | 28053201 | Br J Sports Med | Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review. | 2017 | Details |
| A17005 | 28052624 | Liver Int | The epidemiology of non-alcoholic fatty liver disease. | 2017 | Details |
| A17046 | 28030540 | PLoS One | Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor. | 2016 | Details |
| A17047 | 28029021 | Endocrinol Metab (Seoul) | Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17056 | 28019064 | Hepatol Res | Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus. | 2017 | Details |
| A17059 | 28017631 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. | 2016 | Details |
| A17080 | 28002036 | Rom J Intern Med | Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis. | 2016 | Details |
| A17100 | 27992361 | J Pediatr Endocrinol Metab | Risk factors that affect metabolic health status in obese children. | 2017 | Details |
| A17103 | 27990792 | Minerva Endocrinol | Diabetes mellitus and non-alcoholic fatty liver disease: the thread of Ariadne. | 2016 | Details |
| A17111 | 27986466 | Trends Endocrinol Metab | Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies. | 2016 | Details |
| A17133 | 27973461 | Minerva Endocrinol | Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density. | 2016 | Details |
| A17152 | 27956792 | World J Gastroenterol | Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. | 2016 | Details |
| A17154 | 27956025 | Nutr Metab Cardiovasc Dis | Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors. | 2016 | Details |
| A17162 | 27939359 | Pharmacol Res | A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug? | 2016 | Details |
| A17166 | 27936481 | Z Gastroenterol | Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk. | 2016 | Details |
| A17184 | 27923447 | Metabolism | Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. | 2016 | Details |
| A17188 | 27921044 | Visc Med | Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome. | 2016 | Details |
| A17190 | 27920470 | World J Gastroenterol | Nonalcoholic fatty liver disease - A multisystem disease? | 2016 | Details |
| A17192 | 27919310 | J Dev Orig Health Dis | Indicators of fetal growth and adult liver enzymes: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. | 2016 | Details |
| A17199 | 27917437 | Cell Tissue Res | Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis. | 2016 | Details |
| A17201 | 27916783 | Endocr J | Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial. | 2016 | Details |
| A17204 | 27914698 | Nutr Metab Cardiovasc Dis | Under-prescription of statins in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17209 | 27913605 | Eur J Endocrinol | Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. | 2017 | Details |
| A17221 | 27906428 | Eur Rev Med Pharmacol Sci | The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. | 2016 | Details |
| A17238 | 27895393 | World J Gastroenterol | Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease. | 2016 | Details |
| A17245 | 27891128 | Front Immunol | Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. | 2016 | Details |